Drug Type Small molecule drug |
Synonyms Avishot, Eapidil, Naftopidil (JP17/INN) + [15] |
Target |
Action antagonists |
Mechanism ADRA1 antagonists(Adrenergic receptor alpha-1 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization |
Drug Highest PhaseApproved |
First Approval Date Japan (25 Dec 1998), |
Regulation- |
Molecular FormulaC24H28N2O3 |
InChIKeyHRRBJVNMSRJFHQ-UHFFFAOYSA-N |
CAS Registry57149-07-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01674 | Naftopidil |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Dysuria | Japan | - | 25 Dec 1998 |
Prostatic Hyperplasia | Japan | - | 25 Dec 1998 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Medical device discomfort | Phase 3 | United States | 01 May 2014 | |
Ureterolithiasis | Phase 3 | United States | 01 May 2014 | |
Pain, Postoperative | Phase 3 | South Korea | 25 Oct 2013 | |
Urinary Bladder, Neurogenic | Phase 2 | Japan | - |
Not Applicable | 99 | izduofocdg(xfnqiubwmx) = nnolkhpanh jbkjwpzdba (fgzwyhrygt ) | Positive | 01 Apr 2011 | |||
izduofocdg(xfnqiubwmx) = jbselixebd jbkjwpzdba (fgzwyhrygt ) | |||||||
Not Applicable | 212 | lleyfisooj(qikbupaqnb) = eumiwonffu bhwfhurnav (hxxmbgkoxh ) | Positive | 01 Apr 2011 | |||
lleyfisooj(qikbupaqnb) = cjphrixmhu bhwfhurnav (hxxmbgkoxh ) |